药石科技(300725.SZ)发布上半年业绩，归母净利润7249.81万元，下降26.54%

Core Viewpoint - The company reported a revenue of 920 million yuan for the first half of 2025, reflecting a year-on-year growth of 23.48%, while the net profit attributable to shareholders decreased by 26.54% [1] Financial Performance - Revenue for the first half of 2025 reached 920 million yuan, marking a 23.48% increase compared to the previous year [1] - Net profit attributable to shareholders was 72.5 million yuan, which represents a decline of 26.54% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 59.6 million yuan, down 11.82% year-on-year [1] - Basic earnings per share stood at 0.36 yuan [1]